Status: Not yet recruiting
Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies
Phase 1/2a Study of RP-001 in participants with Advanced Malignancies
Participants needed: 66
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Recurv Pharma IncUpdated: Mar 31, 2026
Eligibility criteria
Phase 1: Participants with solid tumors who are candidates for treatment with a... [+1]
1. Active infection requiring systemic anti-infective therapy within 28 days pri...